Clinical Trials on 酸中毒，呼吸
Total 0 results
Nothing found
Sponsors and Collaborators
- YuceBio Technology Co., Ltd.
- CARERS TRUST (Carers Trust), UK
- Pak Emirates Military Hospital Rawalpindi
- Institute of Population Research, Peking University
- Cook County Health & Hospitals System
- Department of Gastroenterology, "Grigore T. Popa" University of Medicine and Pharmacy, Romania
- Barth Wilsey
- S&T Medical Technologies, Inc.
- Louisville VA Medical Center
- King Saud University
- Common Room Consulting Ltd
- Michael Zell, MD
- Mrs Hiroko Yuzawa, MD, PhD(c); Department of Intensive Care Medicine, Tokyo, Japan
- Zogenix, Inc.
- Momotaro-Gene Inc.
- Chin-Tsung Shen
- Home care nursing in the Municipality of Esbjerg
- Allorion Therapeutics Inc
- West of Scotland Lymphoma Group
- OLVG
- View Full List
Medical Conditions
- Locally Advanced or Metastatic Prostate Cancer.
- Metastatic or Recurrent Head and Neck Squamous Cell Cancer
- Granulocyte/ Polymorphonuclear Cells
- Excitotoxicity
- Focus of the Study is Satiety
- Caridovascular Disease
- Degenerative Lumbar Diseases
- Infant Amino Acid Profile at Day 3 and Discharge
- HR+HER2- Breast Cancer
- Solid Tumors With Documented BRCA, BARD, or PALB or Other Acceptable DNA Mutations or Anomalies That Are Scientifically Sound
- Sexual Wellbeing
- Polyneuropathy and Mononeuropathies
- COPD - Chronic Obstructive Pulmonary Disease
- HODGKIN LYMPHOMA
- Malalignment, Bone
- Peripheral Microvascular Symptoms
- Antiphospholipid Syndrome
- Complications, Postoperative
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV 2 Infection)
- Platelet-aggregation Inhibitors
- View Full List
Drug Interventions
- Dexmedetomidine injection
- Pre-study antiretroviral regimen
- IDX-1197
- 120 mg Pseudoephedrine hydrochloride extended release tablets
- Pulmozyme
- Plerixafor
- Pleyris
- Gardasil
- Local medical treatment of raised intraocular pressure
- Lamictal
- HM30181AK 15mg
- Linagliptin
- Standard care Hyaluronic acid eye drops
- PP4001
- 4-Demethyl-4-cholestryloxycarbonylpenclomedine
- Nilotinib 400 mg BID
- Cohort 2 Probe Substrate
- Intensive chemotherapy
- Erenumab Dose 2
- GSK1247303
- View Full List
CROs by country
- Contract Research Organizations in Algeria
- Contract Research Organizations in Belarus
- Contract Research Organizations in Congo
- Contract Research Organizations in Dominican Republic
- Contract Research Organizations in Hong Kong
- Contract Research Organizations in Kosovo
- Contract Research Organizations in Malta
- Contract Research Organizations in Norway
- Contract Research Organizations in Panama
- Contract Research Organizations in Singapore
- Contract Research Organizations in Tunisia
- Contract Research Organizations in United States
- Contract Research Organizations in Uzbekistan
- CRO list by country